To produce cannabinoids in yeast (Saccharomyces cerevisiae), UC Berkeley synthetic biologists first engineered yeast's native mevalonate pathway to provide a high flux of geranyl pyrophosphate ...
Cannabis and endocannabinoids — cannabis-like molecules that occur naturally in the brain — are known to stimulate appetite. In the 12 April Nature, George Kunos and colleagues of the National ...
MIRA Pharmaceuticals signs letter of intent to acquire SKNY Pharmaceuticals, adding SKNY-1, a preclinical drug for weight ...
Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking ...
As cannabis legalization continues to spread across the country, doctors are sounding the alarm about the potential health risks of the quickly changing drug. One rare condition is sending chronic ...
These edibles are pushing the boundaries of what consumers expect, offering a discreet and accessible alternative to ...
Cannabis users with type 1 diabetes (T1D) can be misdiagnosed with diabetic gastroparesis on the basis of symptoms or presentation with or without gastric emptying tests; however, cannabinoid ...
The drug candidate is designed to interact with cannabinoid receptors CB1 and CB2 pathways that have been demonstrated for their role in appetite, metabolism, and energy balance regulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback